Artesunate amodiaquine

DRUG3 trials

Sponsors

National Institute for Medical Research, Tanzania, Medical University of Vienna, University of Oxford

Conditions

MalariaMalaria PaediatricsUncomplicated Falciparum Malaria

Phase 3

Testing new and existing malaria treatments for children in Africa: an adaptive trial of artemisinin-based therapies

Active, not recruitingPACTR202509766285920

Medical University of ViennaMalaria Paediatrics

Start: 2026-06-15Target: 4600Updated: 2026-06-22

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines

RecruitingPACTR202601913078109

University of OxfordMalaria

Start: 2024-03-01Target: 1680Updated: 2026-06-22

Phase 4

Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania

CompletedNCT03431714

National Institute for Medical Research, TanzaniaUncomplicated Falciparum Malaria

Start: 2017-07-14End: 2017-12-08Updated: 2018-02-13

Related Papers

High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.

2019-03-2517 citations